Mycobacterium bovis-bacillus Calmette-Guerin and asthma

Chinese Medical Journal

Volumn 118, Issue 11, 2005, Pages 942-947

  Shen, Hua Hao ^a   Zhang, Gen Sheng ^a   Wang, Ping Li ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Asthma; Bacille Calmette Guerin; Prevention; Vaccination

Indexed keywords

BCG VACCINE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; RECOMBINANT VACCINE; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ANAPHYLACTIC SHOCK; ASTHMA; BACTERIAL STRAIN; BCG VACCINATION; BRONCHUS HYPERREACTIVITY; DENDRITIC CELL; DOSE RESPONSE; DRUG MECHANISM; FEVER; HELPER CELL; HUMAN; IMMUNOSTIMULATION; MYCOBACTERIUM BOVIS; NONHUMAN; REVIEW;

ANIMALS; ASTHMA; BCG VACCINE; DENDRITIC CELLS; HUMANS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TH1 CELLS; VACCINATION;

EID: 20944439231     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Renz H, Herz U. The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur Respir J 2002;19:158-171.
2. Shirakawa T, Enomoto T, Shimazu S, et al. The inverse association between tuberculin response and atopic disorder. Science 1997;275:77-79.
3. Csoma Z, Kemeny L, Boda K, et al. Investigation of the delayed type hypersensitivity reaction in atopic patients. Orv Hetil 2002;143:2235-2239.
4. Ma Y, Li XF, Zhao J, et al. Relationships between the diameters of Bacille Calmette-Guerin scars and asthma, atopy in urban and rural Beijing children. Chin J Tuberc Respir Dis (Chin) 2003;26:526-530.
5. Townley RG, Barlan IB, Patino C, et, al. The effect of BCG vaccine at birth on the development of atopy or allergic disease in young children. Ann Allergy Asthma Immunol 2004;92:350-355.
6. Barlan IB, Tukenmez F, Bahceciler NN. The impact of in vivo Calmette-Guerin Bacillus administration on in vitro IgE secretion in atopic children. J Asthma 2002; 39:239-246.
7. Choi IS and Koh YI. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann Allergy Asthma Immunol 2002;88: 584-591.
8. Choi IS, Koh YI. Effects of BCG revaccination on asthma. Allergy 2003;58:1114-1116.
9. Alm JS, Lilja G, Pershagen G, et al. Early BCG vaccination and development of atopy. Lancet 1997; 350:400-403.
10. Pahari A, Welch S, Lingam S. BCG, tuberculin skin-test results and asthma prevalence in school children in North London. Indian Pediatr 2002;39:254-258.
11. Jentoft HF, Omenaas E, Eide GE, et al. Absence of relationship between tuberculin reactivity and asthmatic symptoms, level of FEV1 and bronchial hyperresponsiveness in BCG vaccinated young adults. Allergy 2002;57:336-340.
12. Bager P, Rostgaard K, Nielsen NM, et al. Age at bacille Calmette-Guerin vaccination and risk of allergy and asthma. Clin Exp Allergy 2003;33:1512-1517.
13. Anderson HR, Poloniecki JD, Strachan DP, et al. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health 2001; 91:1126-1129.
14. Shirtcliffe PM, Easthope SE, Cheng S, et al. The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. Am J Respir Crit Care Med 2001;163:1410-1414.
15. Tsai JJ, Peng HJ, Shen HD. Therapeutic effect of Bacillus Calmette-Guerin with allergen on human allergic asthmatic patients. J Microbiol Immunol Infect 2002;35:99-102.
16. Erb KW, Holloway JW, Sobeck A, et al. Infection of mice with Mycobacerium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998;187:561-569.
17. Hopfenspirger MT, Agrawal DK. AHR, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002;168:2516-2522.
18. Koh YI, Choi IS, Park SC, et al. BCG infection during pre-sensition or even post-sensition inhibits airway sensition in an animal model of allergic asthma. J Korean Med Sci 2000;15:265-272.
19. Yang X, Fan Y, Wang S, et al. Mycobacterial infection inhibits established allergic inflammatory responses via alteration of cytokine production and vascular cell adhesion molecule-1 expression. Immunology 2002; 105:336-343.
20. Lagranderie M, Nahori MA, Balazuc AM, et al. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacerium bovis BCG drive the primary immune response towards a type 1 cytokine production. Immunology 2003;108:352-364.
21. Nahori MA, Lagranderie M, Lefort J, et al. Effects of Mycobacerium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine 2001;19:1484-1495.
22. Marchant A, Goetghebuer T, Ota MO, et al. Newborns develop a Th1-type immune response to Mycobacerium bovis Bacillus Calmette-Guérin vaccination. J Immunol 1999;163:2249-2255.
23. Zhang GS, Shen HH. The preventive effect of bacillus calmette-guerin vaccination in early life on airway inflammation and mucus production in a murine model of asthma. Chin J Tuberc Respir Dis (Chin) 2005;28: 17-21.
24. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol Today 1996; 17:138-146.
25. Power CA, Wei G, Bretscher PA. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect Immun 1998;66:5743-5750.
26. Takabayashi K, Libet L, Chisholm D, et al. Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice. J Immunol 2003;170: 3898-3905.
27. Gruber C, Meinlschmidt G, Bergmann R, et al. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr Allergy Immunol 2002;13:177-181.
28. Marks GB, Ng K, Zhou J, et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol 2003;111:541-549.
29. Hylkema MN, Timens W, Luinge M, et al . The effect of bacillus calmette-guerin immunization depends on the genetic predisposition to Th2-type responsiveness. Am J Respir Cell Mol Biol 2002;27:244-249.
30. Lande R, Giacomini E, Grassi T, et al. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol 2003;170:1174-1182.
31. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001;106:263-266.
32. + T cells play a ivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 1998;157:210-218.
33. Shen HH, Ochkur SI, McGarry MP, et al. A causative relationship exists between eosinophils and the development of allergy pulmonary pathologies in the mouse. J Immunol 2003;170:3296-3305.
34. Wang PL, Shen HH, Wang SB. The effect of Bacillus Calmette-Guerin on airway inflammation and the balance of Th1/Th2 in a murine model of asthma. Chin J Intern Med (Chin) 2004;43:542-543.
35. Barrios C, Brawand P, Berney M, et al. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 1996;26: 1489-1496.
36. Donckier V, Flamand V, Desalle F, et al. IL-12 prevents neonatal induction of transplantation tolerance in mice. Eur J Immunol 1998;28:1426-1430.
37. Ota MO, Vekemans J, Schlegel-Haueter SE, et al. Influence of Mycobacerium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002;168:919-925.
38. Hamzaoui A, Kahan A, Ayed K, et al. T cells expressing the gammadelta receptor are essential for Th2-mediated inflammation in patients with acute exacerbation of asthma. Mediators Inflamm 2002;11: 113-119.
39. Li CQ, Xu YJ, Yang DL, et al. A study of helper T cell Th1/Th2 immune response pattern of gammadeltaT cells in asthma. Chin J Intern Med (Chin) 2004;43: 342-344.
40. Kumar M, Behera AK, Matsuse H, et al. A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice. Immunology 1999;97:515-521.
41. Jain VV, Kline JN. CpG DNA: immunomodulation and remodelling of the asthmatic airway. Expert Opin Biol Ther 2004;4:1533-1540.
42. Agrawal DK, Edwan J, Kandimalla ER, et al. Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma. Int Immunopharmacol 2004;4:127-138.